FDA Adds Six Bulk Drug Substances to Approved Compounding List

Drug Industry Daily
A A
The FDA added six bulk substances to its list of substances approved for use by compounding facilities exempt from certain FDA oversight activities under section 503A of the Food, Drug and Cosmetic Act.

To View This Article:

Login

Subscribe To Drug Industry Daily